Medeon Biodesign (6499) — Free Cash Flow Generation Index
Latest as of March 2022:
0.32x
Medeon Biodesign (6499) has a Free Cash Flow Generation Index of 0.32x as of March 2022. Free cash flow of NT$19.62 Million represents 0% of operating cash flow (NT$60.74 Million). Read debt load of Medeon Biodesign for a breakdown of total debt and financial obligations.
FCF Generation Index
0.32x
Free Cash Flow / Operating CF
Free Cash Flow
NT$19.62 Million
TWD
Operating Cash Flow
NT$60.74 Million
TWD
Capital Expenditures
NT$41.12 Million
TWD
Medeon Biodesign Free Cash Flow Generation Index (2018–2018)
Historical FCF Generation Index trend for Medeon Biodesign across 1 annual periods. Explore 6499 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Medeon Biodesign (2018–2018)
Year-by-year Free Cash Flow Generation Index for Medeon Biodesign. For the full company profile including market capitalisation, see market cap of Medeon Biodesign.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2018 | 0.83x | NT$267.58 Million | NT$322.05 Million | NT$51.14 Million | — |
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).